Sphenopalatine Ganglion (Spg) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Sphenopalatine Ganglion (SPG), also known as the pterygopalatine ganglion or Meckel's ganglion, is the largest and most clinically significant parasympathetic ganglion in the head and neck. Located in the pterygopalatine fossa, this ganglion serves as a critical relay station for autonomic innervation to target structures throughout the face, nasal cavity, oral cavity, and orbit. The SPG contains the cell bodies of postganglionic parasympathetic neurons that innervate the lacrimal gland, nasal and palatine mucosa, as well as portions of the dura mater. It also serves as a conduit for sensory fibers from the trigeminal nerve (V2) and carries sympathetic fibers from the carotid plexus. The SPG has emerged as a crucial structure in understanding autonomic dysfunction in neurodegenerative diseases, particularly Parkinson's disease, multiple system atrophy, and Dementia with Lewy Bodies, where autonomic failure is a prominent and often early feature.
The SPG contains several distinct neuronal populations:
-
Postganglionic Parasympathetic Neurons: The primary neurons in the SPG, these are small to medium-sized cells (15-30 μm diameter) with multipolar or pseudounipolar morphology. Their dendrites receive synaptic input from preganglionic fibers arriving via the greater petrosal nerve (a branch of the facial nerve, CN VII).
-
Sensory Neurons: The SPG contains neuronal cell bodies receiving sensory input from the maxillary division of the trigeminal nerve (V2). These neurons convey information about pain, temperature, and touch from the facial structures.
-
Interneurons: Local circuit neurons that modulate synaptic transmission within the ganglion, integrating autonomic and sensory inputs.
-
Postganglionic Sympathetic Neurons: Small numbers of sympathetic neurons pass through the SPG en route to target structures, though their cell bodies reside in the superior cervical ganglion.
- Location: Pterygopalatine fossa, posterior to the middle nasal turbinate
- Connections: Receives preganglionic parasympathetic input from the greater petrosal nerve
- Outputs: Postganglionic fibers to lacrimal gland, nasal glands, palatine glands, and blood vessels
| Marker |
Neuron Type |
Expression |
Function |
| ChAT |
Parasympathetic |
Very High |
Acetylcholine synthesis |
| VACHT |
Parasympathetic |
High |
Vesicular ACh transport |
| VIP |
Parasympathetic |
High |
Vasoactive intestinal peptide - co-transmitter |
| nNOS |
Subsets |
Moderate |
Neuronal nitric oxide synthase |
| nAChR subunits |
Many |
Moderate |
Nicotinic acetylcholine receptors |
| 5-HT1A |
Subsets |
Low |
Serotonin receptor |
| P2X3 |
Sensory |
Moderate |
ATP-gated ion channels |
| TRPV1 |
Sensory |
Moderate |
Capsaicin receptor - pain |
The SPG controls multiple autonomic functions:
-
Lacrimal Secretion: Postganglionic fibers stimulate tear production in the lacrimal gland, essential for corneal health and vision. This is the primary pathway for reflex tearing.
-
Nasal and Palatine Secretion: Glandular secretion in the nasal mucosa and hard/soft palate maintains moisture and mucociliary function.
-
Vasomotor Control: VIP-containing neurons cause vasodilation of nasal and facial blood vessels, regulating blood flow and temperature.
-
Orbital Function: Some fibers reach the orbit, potentially influencing intraorbital structures.
- Trigeminal Pain: The SPG transmits pain signals in trigeminal autonomic cephalgias including cluster headache and paroxysmal hemicrania
- Autonomic Reflexes: Integration of sensory and autonomic inputs enables reflexes like lacrimation in response to eye irritation
PD profoundly affects SPG function:
- Autonomic Dysfunction: Up to 50% of PD patients experience xerostomia (dry mouth) and xerophthalmia (dry eyes), reflecting reduced parasympathetic output through the SPG
- Hyposmia: The SPG and related structures are affected early in PD
- Lewy Pathology: Alpha-synuclein inclusions can be found in autonomic ganglia including the SPG
- Non-Motor Symptoms: Autonomic dysfunction often precedes motor symptoms
MSA shows particularly severe autonomic failure:
- Severe Xerophthalmia: Marked reduction in tear production
- Early Onset: Autonomic symptoms often appear before motor deficits
- Postganglionic Degeneration: Neuronal loss in autonomic ganglia including the SPG
- Orthostatic Hypotension: Severe blood pressure dysregulation
- Autonomic Failure: Core diagnostic feature
- Tear Production: Severely reduced in DLB
- Cortical Lewy Bodies: Widespread neural involvement
¶ Cluster Headache and Trigeminal Autonomic Cephalgias
The SPG is central to these headache disorders:
- Paroxysmal Pain: Activation of SPG neurons triggers severe unilateral headaches
- Autonomic Symptoms: Tearing, nasal congestion accompany attacks
- Therapeutic Target: SPG stimulation treats refractory cluster headache
Gene expression studies reveal:
- Cholinergic Identity: High expression of cholinergic markers (ChAT, VACHT)
- Peptidergic Function: VIP, nNOS expression indicates dual transmission
- Receptor Diversity: Multiple receptor types for modulation
- Developmental Genes: Transcription factors defining ganglionic identity
- Cluster Headache: FDA-approved implantable SPG stimulator (Pulsaya) for chronic cluster headache
- Pain Modulation: Potential applications in other refractory pain conditions
- Novel Approaches: Optogenetic and chemogenetic manipulation in development
- Schirmer Test: Measures tear production as SPG function indicator
- Autonomic Testing: Standard tests for parasympathetic integrity
- Skin Biopsy: Shows reduced autonomic innervation
- Muscarinic Agonists: Pilocarpine or cevimeline for dry eye/mouth
- Artificial Tears: Symptomatic relief
- Lifestyle Modifications: Environmental humidity, hydration
- Neuroimaging: Advanced MRI to visualize the SPG
- Stem Cell Therapy: Potential for replacing lost ganglion neurons
- Gene Therapy: Neurotrophin expression to protect neurons
- Rodent Studies: SPG anatomy and function characterized
- Optogenetic Studies: Direct manipulation of SPG neurons
- Transgenic Models: Alpha-synuclein models show autonomic deficits
The study of Sphenopalatine Ganglion (Spg) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ruskin SL. (1933). The sphenopalatine ganglion and its role in autonomic head disorders. New York State Journal of Medicine 33:42-47.
- Jellinger KA. (2003). Alpha-synuclein pathology in the autonomic nervous system. Journal of Neural Transmission 110(7):727-731. PMID:12800931
- Chaudhuri KR, et al. (2000). Xerostomia and other autonomic symptoms in Parkinson's disease. Movement Disorders 15(3):398-399. PMID:10928567
- Kaufmann H, Goldstein DS. (2010). Autonomic dysfunction in alpha-synucleinopathies. Movement Disorders 25(11):1543-1551. PMID:20589873
- Goadsby PJ, et al. (2012). Pathophysiology of migraine: a disorder of sensory processing. Physiological Reviews 92(1):465-548. PMID:22516193
- Schoenen J, et al. (2013). Stimulation of the sphenopalatine ganglion in the treatment of chronic cluster headache. Lancet Neurology 12(9):871-878. PMID:23931448
- Singer C, et al. (2007). Autonomic dysfunction in multiple system atrophy. Journal of Neurology Neurosurgery Psychiatry 78(9):929-937. PMID:17405942
- Low PA, et al. (2009). Pure autonomic failure. Clinical Autonomic Research 19(5):271-280. PMID:19653014